Liquid antisolvent precipitation process for solubility modulation of bicalutamide
By: Tarique Meer, Kiran Sawant and Purnima Amin
Open Access
|Dec 2011References
- D. R. Vega, G. Polla, A. Martinez, E. Mendioroz and M. Reionoso, Conformational polymorphism in bicalutamide,(2007) 112-118; DOI: 10.1016/j.ijpharm.2006.08.001.
- D. Wu, J. Yang, V. A. Nair, D. D. Miller and J. T. Dalton, Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic chrecteristics of a propanamide in preclinical study,(2006) 483-494; DOI: 10.1124/dmd.105.006643.
- Y. Le, H. Ji, J. F. Chen, Z. Shen, J. Yun and M. Pu, Nanosized bicalutamide and its molecular structure in solvents,(2009) 175-180; DOI: 10.1016/j.ijpharm.2008.11.025.
- A. Abdalla and K. Mäder, Preparation and characterization of a self-emulsifying pellet formulation,(2007) 220-226; DOI: 10.1016/j.ejpb.2006.11.015.
- I. Kanfer, Report on the international workshop on the biopharmaceutics classification system (BCS): scientific and regulatory aspects in practice,(2000) 1-4.
- P. Kocbek, S. Baumgartner and J. Kristl, Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs,(2006) 179-186; DOI: 10.1016/j.ijpharm.2006.01.008.
- Y. Dong, W. N. Kiong, S. Shen, S. Kim and R. B. H. Tan, Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation,(2009) 84-88; DOI: 10.1016/j.ijpharm.2009.03.013.
- A. Balakrishnan, B. D. Rege, G. L. Amidon and J. E. Polli, Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity,(2004) 2064-2075; DOI: 10.1002/jps.20118.
- G. S. Jadhav and P. R. Vavia, Physicochemical in silico and in-vivo evaluation of danazole-β-cyclodextrin complex,(2008) 5-16 DOI: 10.1016/j.ijpharm.2007.10.005.
- I. Ilić, R. Dreu, M. Burjak, M. Homar, J. Kerč and J. S. Srčič, Microparticle size control and glimepiride microencapsulation using spray congealing technology,(2009) 176-183; DOI: 10.1016/j.ijpharm.2009.05.011.
- M. D. Moore and P. L. D. Wildfong, Aqueous solubility enhancement through engineering of binary solid composites: pharmaceutical applications,(2009) 36-49; DOI: 10.1007/s12247-009-9053-7.
- P. Zhang, H. Ye, T. Min and C. Zhang, Water soluble poly(ethylene glycol) prodrug of silybin: design, synthesis, and characterization,(2008) 3230-3235; DOI: 10.1002/app.27450.
- Y. Le, H. Ji, J. Chen, Z. Shen, J. Yun and M. Pu, Nanosized bicalutamide and its molecular structure in solvents,(2009) 175-180 DOI: 10.1016/j.ijpharm.2008.11.025.
- R. P. Bagwe and K. C. Khilar, Effects of the intermicellar exchange rate and cations on the size of silver chloride nanoparticles formed in reverse micelles of AOT,(1997) 6432-6438; DOI: 10.1021/la980248q.
- J. Y. Zhang, Z. G. Shen, J. Zhong, T. T. Hu, J. F. Chen, Z. Q. Ma and J. Yun, Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants,(2006) 153-160; DOI: 10.1016/i.ijpharm.2006.05.048.
- U. S. Food and Drug Administration, Dissolution Methods, Bicalutamide, FDA, Silver Sping (MD), Dec 15 2005;
Language: English, Croatian
Page range: 435 - 445
Published on: Dec 25, 2011
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:
© 2011 Tarique Meer, Kiran Sawant, Purnima Amin, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.